PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'GIS-EPIPHARE, Groupement d\'intérêt scientifique Epidémiologie des produits de santé ANSM-CNAM, Paris, F-75020, France.\', \'Univ Paris-Est Creteil, EpiDermE, Créteil, F-94010, France.\', \'Caisse Nationale d\'assurance Maladie des Travailleurs Salariés (CNAM), Paris, F-75020, France.\', \'INSERM, Echappement aux anti-infectieux et Pharmacoépidémiologie, CESP, UVSQ, Montigny le Bretonneux, F-78180, France.\', \'AP-HP, Hôpitaux universitaires Henri Mondor, Département de Dermatologie, UPEC, Créteil, F-94010, France.\', \'INSERM, Centre d\'Investigation Clinique 1430, Créteil, F-94010, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/bjd.20659
?:doi
?:hasPublicationType
?:journal
  • The British journal of dermatology
is ?:pmid of
?:pmid
?:pmid
  • 34310699
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all